Detailed information for compound 1261789

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 446.492 | Formula: C26H24F2N4O
  • H donors: 2 H acceptors: 2 LogP: 3.98 Rotable bonds: 5
    Rule of 5 violations (Lipinski): 1
  • SMILES: Fc1ccc(cc1)[C@@H]1N[C@H](c2ccc(cc2)F)C2/C(=N\NC(=O)c3ccncc3)/C1CCC2
  • InChi: 1S/C26H24F2N4O/c27-19-8-4-16(5-9-19)23-21-2-1-3-22(24(30-23)17-6-10-20(28)11-7-17)25(21)31-32-26(33)18-12-14-29-15-13-18/h4-15,21-24,30H,1-3H2,(H,32,33)/b31-25-/t21?,22?,23-,24+/m0/s1
  • InChiKey: ADAVHGXWTWEPRF-PIIZVJCKSA-N  


Substructure search Similarity search

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity
Obtained from network model

Ranking Plot

Putative Targets List

Species Potential target Raw Global Species
Echinococcus multilocularis c4b binding protein beta chain 0.0015 0 0.5
Toxoplasma gondii rhoptry neck protein RON1 0.0015 0 0.5
Onchocerca volvulus 0.0015 0 0.5
Onchocerca volvulus 0.0015 0 0.5
Onchocerca volvulus 0.0015 0 0.5
Plasmodium falciparum apical sushi protein 0.0015 0 0.5
Onchocerca volvulus 0.0015 0 0.5
Echinococcus multilocularis C type lectin domian containing protein 0.0015 0 0.5
Onchocerca volvulus 0.0015 0 0.5
Onchocerca volvulus 0.0015 0 0.5
Echinococcus granulosus C type lectin domian containing protein 0.0015 0 0.5
Loa Loa (eye worm) hypothetical protein 0.0019 1 1
Onchocerca volvulus 0.0015 0 0.5
Onchocerca volvulus 0.0015 0 0.5
Plasmodium vivax apical sushi protein, putative 0.0015 0 0.5
Onchocerca volvulus 0.0015 0 0.5
Loa Loa (eye worm) hypothetical protein 0.0017 0.4835 0.4835
Onchocerca volvulus 0.0015 0 0.5
Toxoplasma gondii rhoptry neck protein RON9 0.0015 0 0.5
Echinococcus granulosus c4b binding protein beta chain 0.0015 0 0.5
Schistosoma mansoni c4b-binding protein beta chain 0.0015 0 0.5

Activities

Activity type Activity value Assay description Source Reference
Activity (functional) = 67.63 % Antitubercular activity against isoniazid-resistant Mycobacterium tuberculosis assessed as reduction of relative light unit at 1 ug/ml after 72 hrs by luciferase reporter phage assay relative to control ChEMBL. 20822833
Activity (functional) = 75.08 % Antitubercular activity against isoniazid-resistant Mycobacterium tuberculosis assessed as reduction of relative light unit at 2 ug/ml after 72 hrs by luciferase reporter phage assay relative to control ChEMBL. 20822833
MIC (functional) = 50 ug ml-1 Antifungal activity against Candida albicans-6 NCIM C27 after 72 to 96 hrs by twofold serial dilution method ChEMBL. 20822833
MIC (functional) = 50 ug ml-1 Antifungal activity against Candida albicans NCIM C27 after 72 to 96 hrs by twofold serial dilution method ChEMBL. 20822833
MIC (functional) = 50 ug ml-1 Antifungal activity against Candida albicans-51 NCIM C27 after 72 to 96 hrs by twofold serial dilution method ChEMBL. 20822833
MIC (functional) = 100 ug ml-1 Antibacterial activity against Escherichia coli NCIM 2345 after 24 hrs by twofold serial dilution method ChEMBL. 20822833

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.